Progranulin variability has no major role in Parkinson disease genetic etiology

Neurology

Volumn 71, Issue 15, 2008, Pages 1147-1151

  Nuytemans, K ^a,b,c   Pals, P ^b,d   Sleegers, K ^a,b,c   Engelborghs, S ^b,c,e   Corsmit, E ^a,b,c   Peeters, K ^a,b,c   Pickut, B ^e   Mattheijssens, M ^a,b,c   Cras, P ^b,d   De Deyn, P P ^b,c,e   Theuns, J ^a,b,c   Broeckhoven, C Van ^a,b,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e Memory Clinic and Department of Neurology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; GLUTAMIC ACID; METHIONINE; PROGRANULIN; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SEQUENCE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; AMINO ACID SEQUENCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS; VARIATION (GENETICS);

EID: 55249086715     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000327563.10320.2b     Document Type: Article

References (24)

1. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442: 916-919.
2. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442: 920-924.
3. Pickering-Brown SM, Baker M, Gass J, et al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain 2006;129:3124-3126.
4. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15:2988-3001.
5. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008;131:706-720.
6. Bronner IF, Rizzu P, Seelaar H, et al. Progranulin mutations in Dutch familial frontotemporal lobar degeneration. Eur J Hum Genet 2007;15:369-374.
7. Gijselinck I, van der Zee J, Engelborghs S, et al. Progranulin locus deletion in frontotemporal dementia. Hum Mutat 2008;29:53-58.
8. Schymick JC, Yang Y, Andersen PM, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry 2007;78:754-756.
9. van der Zee J, Le Ber I, Maurer-Stroh S, et al. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 2007;28:416.
10. Cruts M, Van Broeckhoven C. Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet 2008;24:186-194.
11. Sleegers K, Brouwers N, Maurer-Stroh S, et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 2008;71:253-259.
12. Brouwers N, Sleegers K, Engelborghs S, et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology Epub 2008 Jun 18.
13. Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in progranulin. Neurobiol Aging Epub 2007 Oct 18.
14. Gijselinck I, Van Broeckhoven C, Cruts M. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum Mut Epub 2008 Jun 9.
15. Shankaran SS, Capell A, Hruscha AT, et al. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J Biol Chem 2008;283:1744-1753.
16. Pals P, Van Everbroeck B, Grubben B, et al. Case-control study of environmental risk factors for Parkinson's disease in Belgium. Eur J Epidemiol 2003;18:1133-1142.
17. Engelborghs S, Dermaut B, Goeman J, et al. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 2003;74:1148-1151.
18. van der Zee J, Rademakers R, Engelborghs S, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 2006; 129:841-852.
19. Pickering-Brown SM, Rollinson S, Du PD, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 2008;131:721-731.
20. Spina S, Murrell JR, Huey ED, et al. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. Neurology 2007;68:820-827.
21. Brouwers N, Nuytemans K, van der Zee J, et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol 2007;64: 1436-1446.
22. Behrens MI, Mukherjee O, Tu PH, et al. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord 2007;21: 1-7.
23. Mukherjee O, Pastor P, Cairns NJ, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 2006;60:314-322.
24. Leverenz JB, Yu CE, Montine TJ, et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain 2007;130:1360-1374.